PE29798A1 - Acetidinas - Google Patents

Acetidinas

Info

Publication number
PE29798A1
PE29798A1 PE1996000960A PE00096096A PE29798A1 PE 29798 A1 PE29798 A1 PE 29798A1 PE 1996000960 A PE1996000960 A PE 1996000960A PE 00096096 A PE00096096 A PE 00096096A PE 29798 A1 PE29798 A1 PE 29798A1
Authority
PE
Peru
Prior art keywords
compounds
ilo
alkylene
acetidins
tachycinine
Prior art date
Application number
PE1996000960A
Other languages
English (en)
Inventor
Donald Stuart Middleton
Sandra Dora Meadows
Allan Patrick Marchington
Alexander Roderick Mackenzie
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of PE29798A1 publication Critical patent/PE29798A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: R ES FENILO o CICLOALQUILO C3-C7 OPCIONALMENTE SUSTITUIDO CON ALQUILO C1-C6, ENTRE OTROS; "A" ES CO o SO2; m ES PREFERENTEMENTE 0 o 1; R1 ES PREFERENTEMENTE 3,4 DICLOFENILO; "X" ES ALQUILENO C1-C4; "X1" ES UN ENLACE DIRECTO O ALQUILENO C1-C6; R2 ES MORFOLINO, 4-AMINOSULFONILPIPERAZIN-1-ILO o 4-METANOSULFONILPIPARAZIN-1-ILO, ENTRE OTROS. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE (I) Y A LOS COMPUESTOS INTERMEDIOS EN SU OBTENCION. LOS COMPUESTOS OBTENIDOS SON ANTAGONISTAS DE TAQUICININA, QUE ACTUAN SOBRE LOS RECEPTORES DE LA NEUROKININA (NK1, NK2, NK3 O UNA COMBINACION DE DOS O MAS DE LOS MISMOS), SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, ENTRE OTRAS
PE1996000960A 1996-01-05 1996-12-27 Acetidinas PE29798A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600235.7A GB9600235D0 (en) 1996-01-05 1996-01-05 Therapeutic agents

Publications (1)

Publication Number Publication Date
PE29798A1 true PE29798A1 (es) 1998-06-11

Family

ID=10786682

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000960A PE29798A1 (es) 1996-01-05 1996-12-27 Acetidinas

Country Status (38)

Country Link
US (1) US6242438B1 (es)
EP (1) EP0871623B1 (es)
JP (2) JP3123611B2 (es)
KR (1) KR100275402B1 (es)
AP (1) AP709A (es)
AR (2) AR005338A1 (es)
AT (1) ATE232526T1 (es)
AU (1) AU708282B2 (es)
BG (1) BG102589A (es)
BR (1) BR9612412A (es)
CA (1) CA2237189C (es)
CO (1) CO4750815A1 (es)
CZ (1) CZ209398A3 (es)
DE (1) DE69626220T2 (es)
DK (1) DK0871623T3 (es)
DZ (1) DZ2155A1 (es)
ES (1) ES2190486T3 (es)
GB (1) GB9600235D0 (es)
HR (1) HRP970006A2 (es)
HU (1) HUP9903590A3 (es)
IL (2) IL145324A0 (es)
IS (1) IS1876B (es)
MA (1) MA26417A1 (es)
NO (1) NO311838B1 (es)
NZ (1) NZ324712A (es)
OA (1) OA10863A (es)
PE (1) PE29798A1 (es)
PL (1) PL185723B1 (es)
RU (1) RU2158264C2 (es)
SI (1) SI0871623T1 (es)
SK (1) SK89598A3 (es)
TN (1) TNSN96174A1 (es)
TR (1) TR199801268T2 (es)
TW (1) TW472054B (es)
UY (1) UY24429A1 (es)
WO (1) WO1997025322A1 (es)
YU (1) YU71496A (es)
ZA (1) ZA9747B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714129D0 (en) 1997-07-04 1997-09-10 Pfizer Ltd Azetidines
AU1089599A (en) * 1997-10-15 1999-05-03 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
ATE297906T1 (de) * 1997-12-04 2005-07-15 Sankyo Co Alicyclische acylierte heterocyclenderivate
GB9821898D0 (en) * 1998-10-08 1998-12-02 Pfizer Ltd Heterocycles
WO2001095904A1 (en) * 2000-06-12 2001-12-20 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
US6642226B2 (en) 2001-02-06 2003-11-04 Hoffman-La Roche Inc. Substituted phenyl-piperidine methanone compounds
GB0130261D0 (en) 2001-12-18 2002-02-06 Pfizer Ltd Lactams as tachykinin antagonists
US7674783B2 (en) * 2002-11-22 2010-03-09 Dimera Inc. Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
JP4660199B2 (ja) * 2002-12-23 2011-03-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換１−ピペリジン−４−イル−４−アゼチジン−３−イル−ピペラジン誘導体およびそれらのニューロキニン拮抗薬としての使用
TW200508221A (en) 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
WO2006002350A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
NZ551603A (en) 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
ATE478075T1 (de) 2005-03-08 2010-09-15 Janssen Pharmaceutica Nv Diazaspiro-ä4,4ü-nonanderivate als neurokinin- (nk1)-antagonisten
AR057828A1 (es) 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
KR20090112722A (ko) 2007-01-24 2009-10-28 글락소 그룹 리미티드 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 ｒ(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 ｎｋ1을 포함하는 제약 조성물
TW201026666A (en) * 2008-12-16 2010-07-16 Astrazeneca Ab Quaternary piperidine derivatives and uses thereof
RU2011147200A (ru) * 2009-04-22 2013-05-27 Янссен Фармацевтика Нв Азетидинилдиамиды в качестве ингибиторов моноациглицерин-липазы

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
DK0696280T3 (da) * 1993-05-06 1998-01-12 Merrell Pharma Inc Substituerede pyrrolidin-3-yl-alkyl-piperidiner anvendelige som tachykinin-antagonister
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
GB9601202D0 (en) * 1996-01-22 1996-03-20 Pfizer Ltd Piperidones
GB9812037D0 (en) * 1998-06-04 1998-07-29 Pfizer Ltd Piperidones
GB9821898D0 (en) * 1998-10-08 1998-12-02 Pfizer Ltd Heterocycles

Also Published As

Publication number Publication date
OA10863A (en) 2001-09-27
EP0871623B1 (en) 2003-02-12
KR100275402B1 (ko) 2000-12-15
AP709A (en) 1998-12-22
GB9600235D0 (en) 1996-03-06
EP0871623A1 (en) 1998-10-21
ZA9747B (en) 1998-09-30
UY24429A1 (es) 2001-08-27
YU71496A (en) 1999-11-22
CA2237189A1 (en) 1997-07-17
PL327665A1 (en) 1998-12-21
CZ209398A3 (cs) 1999-04-14
WO1997025322A1 (en) 1997-07-17
BG102589A (en) 1999-09-30
ES2190486T3 (es) 2003-08-01
SK89598A3 (en) 2000-02-14
CA2237189C (en) 2002-09-03
AR005339A1 (es) 1999-04-28
NO982651D0 (no) 1998-06-09
DK0871623T3 (da) 2003-03-31
AU708282B2 (en) 1999-07-29
NZ324712A (en) 1999-05-28
CO4750815A1 (es) 1999-03-31
DE69626220D1 (de) 2003-03-20
IL124309A (en) 2002-11-10
AP9600901A0 (en) 1997-01-31
HUP9903590A3 (en) 2002-01-28
AR005338A1 (es) 1999-04-28
HRP970006A2 (en) 1998-06-30
DE69626220T2 (de) 2003-08-28
US6242438B1 (en) 2001-06-05
IL124309A0 (en) 1998-12-06
TR199801268T2 (xx) 1998-10-21
DZ2155A1 (fr) 2002-10-26
JP3123611B2 (ja) 2001-01-15
IS1876B (is) 2003-05-28
IS4760A (is) 1998-05-28
NO311838B1 (no) 2002-02-04
SI0871623T1 (en) 2003-08-31
AU1195097A (en) 1997-08-01
ATE232526T1 (de) 2003-02-15
MA26417A1 (fr) 2004-12-20
PL185723B1 (pl) 2003-07-31
JP3254205B2 (ja) 2002-02-04
IL145324A0 (en) 2002-06-30
JP2000344741A (ja) 2000-12-12
BR9612412A (pt) 1999-07-13
HUP9903590A2 (hu) 2000-05-28
RU2158264C2 (ru) 2000-10-27
KR19990077027A (ko) 1999-10-25
TNSN96174A1 (fr) 2005-03-15
NO982651L (no) 1998-06-09
TW472054B (en) 2002-01-11
JPH11501667A (ja) 1999-02-09

Similar Documents

Publication Publication Date Title
PE29798A1 (es) Acetidinas
AR003955A1 (es) Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen.
AR025225A1 (es) Feniloxazolidinonas heterociclicas biciclicas sustituidas antibacterianas y composiciones farmacéuticas
DE69616480T2 (de) Piperidinderivate als neurokininantagonisten
ATE319440T1 (de) Antidiabetische mittel
ES2123264T3 (es) 2-((dihidro)pirazolil-3'-oximetilen)-anilidas como agentes pesticidas y fungicidas.
PE20021019A1 (es) Grupos azabiciclicos sustituidos
CO5011115A1 (es) Compuestos y metodos quimioquina
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
PE83999A1 (es) Azetidinas
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
ES2183331T3 (es) Inhibidores de sulfamida-metaloproteasa.
ES2054725T3 (es) Heteroaromatos anulares de cinco miembros de p-fenoxi-fenoximetilo.
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
PT1089625E (pt) Agentes ectoparasiticidas
ATE402168T1 (de) Heterocyclische topoisomerase toxine
BR9914255A (pt) Derivados de indolina como agentes de proteção de luz
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
PE109998A1 (es) Compuestos de pirrolidinil y pirrolinil etilamina como agonistas kappa
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
DK415789A (da) Tetracykliske antidepressive midler
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
AR009452A1 (es) Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos.
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EA200100152A1 (ru) Замещенные пиперазиноны и их терапевтическое применение

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed